CompletedNCT06957054

Neural Biomarkers in Fragile X Syndrome

Studying Fragile X syndrome

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Connecta Therapeutics, S.L.
Principal Investigator
Rafael De la Torre Fornell, Pharm, PhD
Hospital del Mar Research Institute
Intervention
Any(other)
Enrollment
20 enrolled
Eligibility
18-55 years · All sexes
Timeline
20242025

Study locations (2)

Collaborators

Hospital del Mar Research Institute (IMIM) · Corporacion Parc Tauli · Ministry of Science and Innovation, Spain

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06957054 on ClinicalTrials.gov

Other trials for Fragile X syndrome

Additional recruiting or active studies for the same condition.

See all trials for Fragile X syndrome

← Back to all trials